ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266047 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266047; 2) Community: the network communities that were significantly associated with the response to NSC 266047; 3) Molecule: the relationships between components within communities and NSC 266047; 4) MDR: the compounds that were significantly associated with the NSC 266047.

NSC Compound Enrichment Correlation
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0421163101172308 0.43712981
NSC 373980 Null 0.0421163101172308 0.47199122
NSC 38643 Lenamycin 0.0421163101172308 0.28141411
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0421163101172308 0.23862631
NSC 621336 Null 0.0421163101172308 0.32694686
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0421163101172308 0.41665524
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0421163101172308 0.19959652
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0421163101172308 0.49954997
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0421163101172308 0.27736053
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0421163101172308 0.49941907
Total:138  Current:129    [First] [Prev] [Next] [Last]